Vaxart (VXRT) News Today $0.70 +0.02 (+2.95%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 23, 2024 | americanbankingnews.comVaxart (NASDAQ:VXRT) Stock Price Passes Below 200 Day Moving Average of $0.91July 18, 2024 | americanbankingnews.comVaxart (NASDAQ:VXRT) & Vir Biotechnology (NASDAQ:VIR) Critical SurveyJuly 9, 2024 | marketbeat.comVaxart (NASDAQ:VXRT) Stock Passes Below 200-Day Moving Average of $0.91Vaxart (NASDAQ:VXRT) Stock Crosses Below Two Hundred Day Moving Average of $0.91June 28, 2024 | marketbeat.comVaxart (NASDAQ:VXRT) Stock Passes Below Two Hundred Day Moving Average of $0.90Vaxart (NASDAQ:VXRT) Stock Passes Below Two Hundred Day Moving Average of $0.90June 21, 2024 | insidertrades.comVaxart, Inc. (NASDAQ:VXRT) Director W. Mark Watson Acquires 20,000 SharesJune 17, 2024 | globenewswire.comVaxart Provides Business UpdateJune 13, 2024 | globenewswire.comVaxart Announces $40 Million Underwritten Offering of Common StockJune 13, 2024 | globenewswire.comVaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine CandidateJune 11, 2024 | marketbeat.comVaxart (NASDAQ:VXRT) Shares Cross Below 200-Day Moving Average of $0.91Vaxart (NASDAQ:VXRT) Stock Passes Below Two Hundred Day Moving Average of $0.91June 3, 2024 | marketbeat.comBrokers Offer Predictions for Vaxart, Inc.'s FY2024 Earnings (NASDAQ:VXRT)Vaxart, Inc. (NASDAQ:VXRT - Free Report) - Analysts at Cantor Fitzgerald reduced their FY2024 earnings per share estimates for Vaxart in a report released on Wednesday, May 29th. Cantor Fitzgerald analyst C. Duncan now expects that the biotechnology company will earn ($0.54) per share for the yeaMay 23, 2024 | globenewswire.comVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 14, 2024 | insidermonkey.comVaxart, Inc. (NASDAQ:VXRT) Q1 2024 Earnings Call TranscriptMay 14, 2024 | finance.yahoo.comVaxart Inc (VXRT) Q1 2024 Earnings Call Transcript Highlights: Promising Developments and ...May 13, 2024 | globenewswire.comVaxart Provides Business Update and Reports First Quarter 2024 Financial ResultsMay 12, 2024 | markets.businessinsider.comVaxart earnings preview: what to expectMay 8, 2024 | marketbeat.comVaxart (VXRT) Scheduled to Post Earnings on MondayVaxart (NASDAQ:VXRT) will be releasing earnings after the market closes on Monday, May 13, Zacks reports.May 7, 2024 | finance.yahoo.comVaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13April 30, 2024 | globenewswire.comVaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating MothersApril 9, 2024 | investorplace.comElection Year Encore: Can 2020's Top 7 Stock Winners Repeat Their Performance in 2024?March 27, 2024 | globenewswire.comVaxart to Present at World Vaccine Congress Washington 2024 on April 3March 22, 2024 | marketbeat.comVaxart, Inc. (NASDAQ:VXRT) Expected to Earn Q1 2024 Earnings of ($0.18) Per ShareVaxart, Inc. (NASDAQ:VXRT - Free Report) - Equities research analysts at B. Riley issued their Q1 2024 earnings estimates for shares of Vaxart in a research note issued on Wednesday, March 20th. B. Riley analyst M. Mamtani expects that the biotechnology company will earn ($0.18) per share for theMarch 21, 2024 | marketbeat.comResearch Analysts Issue Forecasts for Vaxart, Inc.'s Q2 2024 Earnings (NASDAQ:VXRT)Vaxart, Inc. (NASDAQ:VXRT - Free Report) - Investment analysts at B. Riley issued their Q2 2024 earnings per share estimates for Vaxart in a report issued on Wednesday, March 20th. B. Riley analyst M. Mamtani forecasts that the biotechnology company will earn ($0.15) per share for the quarter. B.March 20, 2024 | globenewswire.comVaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 17, 2024 | finance.yahoo.comEstimating The Intrinsic Value Of Vaxart, Inc. (NASDAQ:VXRT)March 15, 2024 | finance.yahoo.comVaxart, Inc. (NASDAQ:VXRT) Q4 2023 Earnings Call TranscriptMarch 14, 2024 | investorplace.comVXRT Stock Earnings: Vaxart Beats EPS, Beats Revenue for Q4 2023March 14, 2024 | finance.yahoo.comVaxart Inc (VXRT) Reports Full Year 2023 Financial ResultsMarch 14, 2024 | globenewswire.comVaxart Provides Business Update and Reports Full Year 2023 Financial ResultsMarch 8, 2024 | marketbeat.comVaxart (VXRT) Set to Announce Quarterly Earnings on ThursdayVaxart (NASDAQ:VXRT) will be releasing earnings after the market closes on Thursday, March 14, Zacks reports.March 7, 2024 | globenewswire.comVaxart to Host Full Year 2023 Business Update and Financial Results Conference Call on March 14March 6, 2024 | marketwatch.comVaxart Names Steven Lo President, Chief ExecutiveMarch 6, 2024 | globenewswire.comVaxart, Inc. Appoints Steven Lo as President, Chief Executive Officer, and DirectorFebruary 20, 2024 | finance.yahoo.comVAXART, INC. (VXRT) Now Trades Above Golden Cross: Time to Buy?February 5, 2024 | finance.yahoo.comVaxart Announces Publication in Vaccines of Non-Human Primate Preclinical Data Demonstrating Its Next-Generation Vaccine Candidates Elicit Mucosal and Systemic Immunogenicity and Reduce Viral Shedding after SARS-CoV-2 ChallengeFebruary 2, 2024 | marketbeat.comBrokers Set Expectations for Vaxart, Inc.'s FY2023 Earnings (NASDAQ:VXRT)Vaxart, Inc. (NASDAQ:VXRT - Free Report) - B. Riley boosted their FY2023 earnings per share estimates for Vaxart in a note issued to investors on Wednesday, January 31st. B. Riley analyst M. Mamtani now expects that the biotechnology company will earn ($0.66) per share for the year, up from theirJanuary 31, 2024 | marketbeat.comVaxart (NASDAQ:VXRT) Raised to "Buy" at B. RileyB. Riley upgraded shares of Vaxart from a "neutral" rating to a "buy" rating and set a $2.00 price target for the company in a research report on Wednesday.January 16, 2024 | marketwatch.comVaxart CEO Resigns; Biotech Raises $10 Million in Stock SaleJanuary 16, 2024 | finance.yahoo.comVaxart, Inc. Announces Management ChangeJanuary 16, 2024 | finance.yahoo.comVaxart Announces $10.0 Million Registered Direct Offering with RA Capital ManagementDecember 21, 2023 | finance.yahoo.comVaxart Announces Last Subject Dosed in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersNovember 7, 2023 | finance.yahoo.comHere's Why Vaxart (NASDAQ:VXRT) Must Use Its Cash WiselyNovember 3, 2023 | finance.yahoo.comVaxart, Inc. (NASDAQ:VXRT) Q3 2023 Earnings Call TranscriptNovember 3, 2023 | finance.yahoo.comVaxart Inc (VXRT) Reports Q3 2023 Financial Results and Business UpdatesNovember 2, 2023 | finance.yahoo.comVaxart Provides Business Update and Reports Third Quarter 2023 Financial ResultsNovember 2, 2023 | finance.yahoo.comVaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating MothersOctober 26, 2023 | finance.yahoo.comVaxart to Host Third Quarter 2023 Business Update and Financial Results Conference Call on November 2September 21, 2023 | finance.yahoo.comVaxart to Participate in Fireside Chat at 2023 Cantor Global Healthcare ConferenceSeptember 10, 2023 | markets.businessinsider.comVaxart (VXRT) Receives a Buy from Cantor FitzgeraldAugust 22, 2023 | finance.yahoo.comStrong week for Vaxart (NASDAQ:VXRT) shareholders doesn't alleviate pain of three-year lossAugust 15, 2023 | finance.yahoo.comBears are Losing Control Over VAXART, INC. (VXRT), Here's Why It's a 'Buy' Now Get Vaxart News Delivered to You Automatically Sign up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter. Email Address Charles Payne Demystifies Options (Ad)Did you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Click here to register for free VXRT Media Mentions By Week VXRT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VXRT News Sentiment▼1.230.66▲Average Medical News Sentiment VXRT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VXRT Articles This Week▼21▲VXRT Articles Average Week Get Vaxart News Delivered to You Automatically Sign up to receive the latest news and ratings for VXRT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Athira Pharma News Today Aligos Therapeutics News Today Inovio Pharmaceuticals News Today Anavex Life Sciences News Today Editas Medicine News Today Aura Biosciences News Today Enanta Pharmaceuticals News Today Cartesian Therapeutics News Today Adaptimmune Therapeutics News Today Akebia Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VXRT) was last updated on 7/28/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxart, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.